COLLAGEN BASED LIGAMENT TEMPLATE FOR ACL RECONSTRUCTION

Information

  • Research Project
  • 2909805
  • ApplicationId
    2909805
  • Core Project Number
    R44AR043549
  • Full Project Number
    5R44AR043549-03
  • Serial Number
    43549
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/10/1995 - 29 years ago
  • Project End Date
    12/31/2001 - 23 years ago
  • Program Officer Name
    PANAGIS, JAMES S.
  • Budget Start Date
    5/1/1999 - 25 years ago
  • Budget End Date
    12/31/2001 - 23 years ago
  • Fiscal Year
    1999
  • Support Year
    3
  • Suffix
  • Award Notice Date
    3/29/1999 - 25 years ago
Organizations

COLLAGEN BASED LIGAMENT TEMPLATE FOR ACL RECONSTRUCTION

DESCRIPTION (Adapted from the applicant's abstract): The overall goal of this research is the design, development and in vivo testing of an engineering type I collagen based ligament template to support the regeneration of the anterior cruciate ligament (ACL) of the knee joint. In the Phase I period, we have accomplished most of the objectives. Specifically, we have designed and developed an extrusion apparatus for the extrusion of collagen filaments; we have tested the extrusion variables for the production of uniform and reproducible filaments: we have studied various crosslinking agents for the toxicity and cytocompatiblity of the various crosslinked materials and defined the most suitable crosslinking agent for crosslinking the filaments; we have defined the overall mechanical strength requirement of the ligament template for canine implantation; and we have implanted the prototypes into eight canin knee joints for ACL reconstruction. During the Phase II, we will continue to improve the design and fabrication procedures and evaluate the safety and efficacy parameters of the collagen ligament template. We will conduct a large scale animal study on the best-defined prototype to evaluate the longer term effects of the implant through the resorption-regeneration-remodeling-maturation phase of the implant The successful results of this Phase II research will likely lead to a clinica trial and commercialization of the product. Nearly 110,000 ACL injuries per year in the U.S. alone and greater than one-third of the injured patients require repair and reconstruction. AC: reconstruction is generally performed by autografting (bone-patellar tendon-bone). In addition to the creation of a second injury site, autograftin often results in pain and strength loss in the quadriceps and requires extende rehabilitation times. There is no ideal method that ensures the restoration of a normal functioning knee. PROPOSED COMMERCIAL APPLICATION: NOT AVAILABLE

IC Name
NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES
  • Activity
    R44
  • Administering IC
    AR
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    846
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    ZRG4
  • Study Section Name
  • Organization Name
    COLLAGEN MATRIX, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    FRANKLIN LAKES
  • Organization State
    NJ
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    07417
  • Organization District
    UNITED STATES